Anxa1 expression seemed to be crucially regulated by FoxM1 through direct interaction with Anxa1 promoter, as mutation of the FoxM1 binding site significantly reduced Anxa1 promoter activity in glioma cells. The gene discussed is FOXM1; the disease is central nervous system cancer.